Biostar Pharma (BSPM) Swings to Q2 Loss
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Biostar Pharmaceuticals,Inc. Announces Its Quarterly and Half Year Results for 2015
August 19, 2015 4:30 PM EDTXIANYANG, China, Aug. 19, 2015 /PRNewswire/ --
Financial Highlights for the Three and Six Months ended June 30, 2015
$14.2 million and $21.1 million net sales for the three and six months ended June 30, 2015, respectively $5.9 million and $9.5 million in gross profits for the three and six months ended June 30, 2015, respectively $1.0 million and $2.0 million spent on research and development during the three and six months ended June 30, 2015, respectively $0.5 million and $0.6 million net losses for the three and six months ended June 30, 2015, respectivelyBiostar Pharmaceuticals, Inc.... More
